#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Craniopharyngioma Gastrointestinal neuroendocrine tumour Barth syndrome Bladder cancer B-cell type acute leukaemia Hereditary spastic paraplegia Idiopathic inflammatory myopathy Immune thrombocytopenia Monogenic diabetes Glomerulonephritis chronic Breast cancer metastatic Lymphangiosarcoma Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Narcolepsy Polymyositis More trials…

    Learn about Rare Diseases

    Rhabdoid tumour Acute respiratory distress syndrome – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information Pleural mesothelioma malignant – Diagnostics Proteus syndrome – Basic Information Combined immunodeficiency – Life with Disease Hereditary hypophosphataemic rickets Angiosarcoma recurrent – Treatment Hepatic angiosarcoma Burkitt’s lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Fluoride (18F) Calcium Chloride Hexahydrate GRNA-001 Padeliporfin Sotalol Mosunetuzumab Gozetotide Naxitamab Tas3351 Tumour Detection Aluminium Oxide, Hydrated Bosutinib Eptacog Beta (Activated) Messenger Rna Encoding Cas9 Botulinum Toxin Type A Emavusertib Clemizole Hydrochloride Avutometinib Cldn6 Car-T(A) Dexamethasone Isonicotinate More therapies…

    Learn about Your Condition

    Vertigo Gastric cancer Duchenne muscular dystrophy Shock Obstructive pancreatitis Deafness neurosensory Hyperchylomicronaemia Angiosarcoma Delirium Uveal melanoma Large cell lung cancer stage 0 Gastrointestinal melanoma Anal fissure Vulvar dysplasia Strongyloidiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Study on Renaparin for Improving Kidney Function in Patients with End-Stage Renal Disease Receiving Deceased Donor Transplants

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Corline Heparin Conjugate
    Austria Germany

  • A study of fosfomycin trometamol treatment for male urinary tract infections in primary care settings

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Fosfomycin Trometamol
    France

  • Study on Rituximab Treatment for Children with Complicated Steroid-Sensitive Nephrotic Syndrome

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Rituximab
    Italy

  • Study of Sildenafil for Men with Erectile Dysfunction to Evaluate Their Ability to Safely Decide on Using This Medication Independently

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Erectile dysfunction
    Investigated Drugs:
    • Sildenafil Citrate
    Poland

  • Study of Ipilimumab and Nivolumab for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 18F-Psma-1007
    • Gozetotide
    • Piflufolastat (18F)
    The Netherlands
Previous Page
1 … 15 16 17 18 19 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!